Oxygenated target waters of cyclotron targets contain long-lived contaminants due to (p,n) reactions in the HAVAR target window that are spalled into the target water. These contaminants are largely removed during the synthesis of the final imaging agent. Currently the USP requires that the final drug product be 99.5% pure, so the total activity of the long-lived contaminants can be no more than 0.5% of the final radiopharmaceutical product. A method has been developed to identify and quantify the primary contaminants using high resolution gamma spectroscopy and VRF, a new spectrum analysis tool. Uptake, retention, and excretion functions for each of the contaminating isotopes in a soluble, injected chemical form have also been calculated using International Commission on Radiological Protection (ICRP) Publication 123 models and are presented in the Appendices A and B of Electronic Supplementary Material. In addition, specific organ and effective dose coefficients were also calculated using ICRP Publication 103 tissue weighting factors and are also presented in the Appendices A and B of Electronic Supplementary Material. Typical imaging agents have contaminant loads far below the USP limit and contribute negligible doses to the patients receiving the drugs.
Introduction
For positron-emission tomography (PET) short-lived radionuclides that emit no gamma-rays but only positrons are required. 18 F is the most commonly-used for this purpose, and is commonly produced by the irradiation of oxygenated water with high-energy protons accelerated from a cyclotron through a Havar [1] window that separates the vacuum of the cyclotron from the water target. In this process long-lived radioactive contaminants are created primarily through (p,n) reactions and are sputtered into the target water. Long-lived contaminants are also created in this process by reaction with secondary neutrons.
Currently the US Pharmacopeial (USP) requires that the final product be 99.5% pure, so the total activity of the long-lived contaminants can be no more than 0.5% of the final radiopharmaceutical product. Among the more notable long-lived contaminants that are evident with gamma spectroscopy are 55 Tc, [2] [3] [4] . The principal (p,n) reactions that produce these contaminants are shown in Table 1 [2] . These contaminants are in all target waters to some extent, and are largely removed using filtration and ion exchange processes in the synthesis of the final drug. The contaminants are both anions and cations and their chemical state may be altered in the process of synthesizing a final imaging agent. Kilian et al. [5] has studied the removal of all of the contaminants during the synthesis of 2-[
18 F]Fluoro-2-deoxy-D-glucose (FDG), the most common imaging agent produced. The contaminants are successfully trapped on filters and the columns for the removal of ionic contaminants. This work indicates that the contaminants retain their original ionic state and are not 
Measurement method
The determination of long lived contaminants in cyclotron produced radiopharmaceuticals is performed by taking a sample of the final drug product and recording the 18 F activity at a specific date and time. Both the end of synthesis (EOS) and the time of expiration are commonly used. The sample is then allowed to decay for 2-3 days to allow the short-lived imaging product to decay away. This decay time is optimal to ensure the analysis has sufficient sensitivity to detect the 55 Co (T 1/2 17.53 h) at the required Minimum Detectable Activity (MDA). The sample is then counted on the high resolution gamma spectrometer (P type crystal) to identify the presence and activity of the long lived contaminants. Typically, one of two commercially available software packages are used to analyze the resulting spectrum and the results are reported, by isotope, as Bq contaminant per MBq of 18 F or 13 N product at the date and time submitted on the chain of custody. The method cannot detect contaminants whose half-lives are too short to make it to the counting laboratory, or pure beta emitters (e.g. 3 H). During validation and verification testing of the new method in samples with significant breakthrough of the long lived contaminants into the final product, it was observed that the commercial software packages based on a Mariscotti [6] peak search algorithm could not adequately resolve and report some of the contaminants due to heavily overlapped spectra. Further, it is not uncommon to have one line with four or more possible isotopes from the library assigned to it. This makes a difficult decision matrix for isotope identification. While final products with heavy loads of the long-lived contaminants are rare, the method needs to be sufficiently robust to manage them when they do appear.
A new gamma spectroscopy analysis tool, VRF [7, 8] , uses an iterative Marquardt algorithm to analyze the spectra. VRF fits all of the lines in the database associated with each radionuclide as a single shape that spans the entire spectrum. These shapes, plus a fitted continuum, are summed to form a Chi squared statistic that is a function of each parameter that is being varied. At each step, the nonlinear least-squares fitting techniques of Levenberg and Marquardt are applied to determine the values of each parameter that yield the minimum possible value of Chi squared. The values for the activities of each nuclide, and their uncertainties, are a direct result of this process. Because shapes for each radionuclide that span the entire spectrum are determined, the full spectrum is fitted and each peak, to include those convoluted with multiple lines, can be quantified.
This new tool is useful for deconvoluting the complex overlapped peaks that sometime appear with these samples. VRF has also been successfully used to analyze other complex spectra from natural sources and resolve the difficult decision matrix where one line could be attributed to several library isotopes [9] . Figures 1, 2 and 3 show a spectrum where many of the isotopes were observed in the final drug, and the deconvolution of the peaks. Table 2 is Fig. 1 The spectrum of contaminants in oxygenated target water from spallation from a Havar window by protons from a cyclotron in the production of 18 F for PET imaging, analyzed with VRF an intercomparison of the results from the different analysis packages used.
Bioassay coefficients and dosimetry
Having identified and quantified the long-lived contaminants in the final drugs, it is also important to determine the radiation dose to the patient that these contaminants deliver.
Retention functions for each possible contaminating isotope were developed for times after injection using the biokinetic models as described in ICRP 123 [10] and are presented in ''Appendix A'' of Electronic Supplementary Material. The effective dose was then calculated for each isotope using the tissue weighting factors from ICRP 103 [11] , and are presented in ''Appendix B'' of Electronic Supplementary Material.
The effective dose to the patient for any possible contaminant load within the USP guidelines is small and poses no significant risk to the patient. Table 2 provides a quantitative comparison of activity concentrations in Bq/GBq, and their one-standard-deviation uncertainties, as analyzed with whole-spectrum shape fitting with VRF, compared to results of analysis with standard peak-search software (denoted as ''SPS''). Tc (in italics, gray type) were grouped with a suffix of ''x'' for all isomers of that nuclide. The standard peak-search software made no separate identification of 95m Tc, presumably due to the interference of the peak of 54 Mn at 834.85 keV with the peak of 95m Tc at 835.13 keV, as shown graphically in Fig. 2 . The tungsten x-rays were incorrectly identified by the standard peak-search software as 
